These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23264626)

  • 1. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice.
    Ma QL; Zuo X; Yang F; Ubeda OJ; Gant DJ; Alaverdyan M; Teng E; Hu S; Chen PP; Maiti P; Teter B; Cole GM; Frautschy SA
    J Biol Chem; 2013 Feb; 288(6):4056-65. PubMed ID: 23264626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
    Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
    Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
    Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
    Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn depletion ameliorates tau
    Liu G; Fiock KL; Levites Y; Golde TE; Hefti MM; Lee G
    Acta Neuropathol Commun; 2020 Jul; 8(1):108. PubMed ID: 32665013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
    Li C; Götz J
    J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
    Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
    Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.
    Xie M; Wang SH; Lu ZM; Pan Y; Chen QC; Liao XM
    J Mol Neurosci; 2014 May; 53(1):59-68. PubMed ID: 24323362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
    Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
    Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
    Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.
    Ittner LM; Ke YD; Delerue F; Bi M; Gladbach A; van Eersel J; Wölfing H; Chieng BC; Christie MJ; Napier IA; Eckert A; Staufenbiel M; Hardeman E; Götz J
    Cell; 2010 Aug; 142(3):387-97. PubMed ID: 20655099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
    Kim E; Sakata K; Liao FF
    PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits.
    Jin YN; Chen PC; Watson JA; Walters BJ; Phillips SE; Green K; Schmidt R; Wilson JA; Johnson GV; Roberson ED; Dobrunz LE; Wilson SM
    PLoS One; 2012; 7(10):e47884. PubMed ID: 23144711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
    Roberson ED; Halabisky B; Yoo JW; Yao J; Chin J; Yan F; Wu T; Hamto P; Devidze N; Yu GQ; Palop JJ; Noebels JL; Mucke L
    J Neurosci; 2011 Jan; 31(2):700-11. PubMed ID: 21228179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.
    Mondragón-Rodríguez S; Trillaud-Doppia E; Dudilot A; Bourgeois C; Lauzon M; Leclerc N; Boehm J
    J Biol Chem; 2012 Sep; 287(38):32040-53. PubMed ID: 22833681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.
    Levenga J; Krishnamurthy P; Rajamohamedsait H; Wong H; Franke TF; Cain P; Sigurdsson EM; Hoeffer CA
    Acta Neuropathol Commun; 2013 Jul; 1():34. PubMed ID: 24252661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
    Tang SJ; Fesharaki-Zadeh A; Takahashi H; Nies SH; Smith LM; Luo A; Chyung A; Chiasseu M; Strittmatter SM
    Acta Neuropathol Commun; 2020 Jul; 8(1):96. PubMed ID: 32611392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
    Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
    Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
    Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B
    Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain.
    Rodriguez Ospina S; Blazier DM; Criado-Marrero M; Gould LA; Gebru NT; Beaulieu-Abdelahad D; Wang X; Remily-Wood E; Chaput D; Stevens S; Uversky VN; Bickford PC; Dickey CA; Blair LJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of synaptic development in the hippocampus of diabetic Goto-Kakizaki rats.
    Matsunaga Y; Negishi T; Hatakeyama A; Kawagoe Y; Sawano E; Tashiro T
    Int J Dev Neurosci; 2016 Oct; 53():58-67. PubMed ID: 27444810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.